Haas tackle high SHBG and low free testosterone, the real reason AOD gets mixed reviews, peptide protocols for gout, Barrett's syndrome, burn recovery, and why lifestyle still beats every compound on the market
A new 2026 study clarifies the muscle loss issue
This triple receptor profile makes it a uniquely valuable reference compound for multi-pathway incretin biology research
Until we have more safety data, tirzepatide remains the more balanced and better-tolerated option
With its ability to promote fullness while reducing caloric intake , this product has become increasingly popular among UK buyers seeking cutting-edge peptide solutions
We changed pharmacy vendor, now you cant get it unless you have had a history of diabetes. Senior Benefits Manager, large manufacturer Weve never offered it for weight loss, and it is still one of our top three prescriptions spends every year. HR Professional, large manufacturer We dont allow GLP-1s for weight loss In our type 2 diabetes population, 50% are utilizing the GLP-1s, so we are now excluding them for anything except type 2 diabetes [to manage costs]. Director of Benefits, large manufacturer The future of GLP-1 drug prices Employers are also recognizing that the price paid by employers for GLP-1 drugs are sometimes higher than online direct-to-consumer prices reflecting manufacturer discounts
